It can reduce cell apoptosis and promote the proliferation of breast cancer cells (e.g., MCF-7) (35–38) by targeting PTEN, tissue factor (TF), interferon (IFN), and MHC I genes (such as HLA-B, HLA-E, HLA-F, and HLA-G). Here, HLA-F is linked to breast carcinoma.